A short overview on the role of α-synuclein and proteasome in experimental models of Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 105-109

  Giorgi, F S ^a   Bandettini Di Poggio, A ^a   Battaglia, G ^b   Pellegrini, A ^a   Murri, L ^a   Ruggieri, S ^b   Paparelli, A ^a   Fornai, F ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; AMPHETAMINE; CATECHOLAMINE; PROTEASOME; UBIQUITIN;

CELL DEATH; CONFERENCE PAPER; CYTOPLASM; DRUG ACTIVITY; DRUG INHIBITION; ENZYMATIC ASSAY; HUMAN; NERVE CELL; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL;

EID: 33750324325     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-45295-0_17     Document Type: Conference Paper

References (12)

1. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306
2. Betarbet R, Sherer TB, Greenamyre JT (2005) Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol 191: S17-S27
3. Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, Capobianco L, Battaglia G, De Blasi A, Nicoletti F, Paparelli A (2004) Methamphetamine produces neuronal inclusions in the nigrostriatal system in PC12 cells. J Neurochem 88: 114-123
4. Fornai F, Lenzi P, Ferrucci M, Lazzeri G, Bandettini diPoggio A, Natale G, Busceti CL, Biagioni F, Giusiani M, Ruggieri S, Paparelli A (2005a) Occurrence of neuronal inclusions combined with increased expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. Brain Res Bull 65: 405-413
5. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2005b) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and α-synuclein. Proc Natl Acad Sci USA 102: 3413-3418
6. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259-272
7. Huang Y, Cheung L, Rowe D, Halliday G (2004) Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 46: 44-70
8. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Saghara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269
9. McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179: 38-46
10. Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochilishi T, Shimura H, Sharon R, Hattori N, Langsten JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS (2002) Parkin localizes to the lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160: 1655-1667
11. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302: 841
12. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388: 839-840